Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
Peer Genetic Coaches for Enhancing Genetic Testing Awareness, Navigation, and Delivery Among African American Men With Metastatic Prostate Cancer, The EXPAND Network
2 other identifiers
observational
30
1 country
1
Brief Summary
This trial evaluates whether a network of peer genetic coaches is useful for addressing disparities in genetic testing and screening among African American men with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). While genetic testing has become central to prostate cancer care, African American men are less likely seek testing due to lack of awareness, cultural beliefs, financial limitations, fear of discrimination, and mistrust in the healthcare system. A network of peer genetic coaches may help address barriers, beliefs, and needs of African American men in the community and provide navigation to increase engagement in genetic testing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2022
CompletedFirst Posted
Study publicly available on registry
November 25, 2022
CompletedStudy Start
First participant enrolled
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2026
CompletedMay 20, 2025
May 1, 2025
1.9 years
November 16, 2022
May 15, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Number of inquiries to the central number (feasibility)
Up to 1 year
Percent of callers screened and eligible to participate (feasibility)
Up to 1 year
Percent of eligible callers who enroll in the study (feasibility)
Up to 1 year
Percent who complete the endpoint assessment (feasibility)
Up to 1 year
Number and percent of men making genetic counseling appointments
Up to 1 year
Secondary Outcomes (3)
Change in decisional conflict for genetic counseling
Baseline up to 1 year
Change in acceptability/attitude toward genetic counseling and testing
Baseline up to 1 year
Change of genetics knowledge
Baseline up to 1 year
Study Arms (1)
Supportive care (training, education, discussion)
AIM 1: Peer genetic coaches undergo training and education on study. AIM 2: Patients receive an educational booklet and attend a discussion with a peer genetic coach on study.
Interventions
Undergo training and education
Receive educational booklet
Attend discussion with peer genetic coach
Eligibility Criteria
Men who have experience with both prostate cancer (PCA) and genetic counseling and testing, as well as peer education or navigation experience. African American men with a history of prostate cancer or with a strong family history of prostate cancer, breast cancer, ovarian cancer, pancreatic cancer, colorectal cancer, uterine cancer, renal cancer, urothelial cancer, or upper bowel cancer.
You may qualify if:
- AIM 1: Are 18 years old or older
- AIM 1: Are able to read and speak English comfortably
- AIM 1: Men who have experience with both prostate cancer (PCA) and genetic counseling and testing will be a priority for training, as well as men who have considerable peer education or navigation experience
- AIM 2: Are 18 years old or older
- AIM 2: Are African American
- AIM 2: Are able to read and speak English comfortably
- AIM 2: Men who meet any one of the following criteria: (1) metastatic prostate cancer; (2) prostate cancer with high-risk features (T3 or higher, Gleason 8 or higher, node positive disease); (3) with or without a diagnosis of prostate cancer with strong family history (2 or more first-degree or second-degree relatives) with prostate cancer (particularly metastatic prostate cancer or died from prostate cancer), breast cancer, ovarian cancer, pancreatic cancer, colorectal cancer, uterine cancer, renal cancer, urothelial cancer, or upper bowel cancer
You may not qualify if:
- Children under the age of 18
- Anyone who has trouble understanding the consent or with significant anxiety detected during the consent process
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Leader, DrPh, MPH
Thomas Jefferson University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 16, 2022
First Posted
November 25, 2022
Study Start
June 3, 2024
Primary Completion
April 29, 2026
Study Completion
April 29, 2026
Last Updated
May 20, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share